![Octávio Costa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Octávio Costa served as Chief Medical Officer at Cornerstone Pharmaceuticals, Inc. and Monopar Therapeutics, Inc. before earning a doctorate degree from Pontifícia Universidade Católica de São Paulo.
| Companies | Position | End |
|---|---|---|
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Chief Tech/Sci/R&D Officer | - |
| MONOPAR THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Pontifícia Universidade Católica de São Paulo
 Pontifícia Universidade Católica de São Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monopar Therapeutics, Inc.
 Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
